Insight Molecular Diagnostics Inc (IMDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Operating Expenses | 5,462 | 3,997 | 4,047 | 3,023 | 4,226 |
| Operating Income | -5,462 | -3,997 | -4,047 | -3,023 | -4,226 |
| Interest Expense | -167 | 19 | 50 | 50 | 56 |
| Other Income | -88 | 152 | -403 | 102 | -223 |
| Pre-tax Income | -5,383 | -3,864 | -4,500 | -2,971 | -4,505 |
| Net Income Continuous | -5,383 | -3,864 | -4,500 | -2,971 | -4,505 |
| Net Income | $-5,383 | $-3,864 | $-4,500 | $-2,971 | $-4,505 |
| EPS Basic Total Ops | -2.00 | -1.60 | -2.20 | -1.40 | -2.40 |
| EPS Basic Continuous Ops | -2.07 | -1.66 | -2.13 | -1.48 | -2.33 |
| EPS Diluted Total Ops | -2.00 | -1.60 | -2.20 | -1.40 | -2.40 |
| EPS Diluted Continuous Ops | -2.07 | -1.66 | -2.13 | -1.48 | -2.33 |
| EBITDA(a) | $-5,359 | $-3,866 | $-3,902 | $-2,886 | $-3,415 |